KIF21B and Alzheimer disease: Other researchers evaluated the expression level of driver protein in AD patients after death, and found that compared with the control group, the expression of KIF21B in AD patients under 62 years old increased by 5 times, and in AD patients between 62 and 72 years old increased by three times (Kreft et al., 2014; Le Guen et al., 2021).